Found: 53
Select item for more details and to access through your institution.
Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future.
- Published in:
- Stem Cells Translational Medicine, 2023, v. 12, n. 2, p. 55, doi. 10.1093/stcltm/szac086
- By:
- Publication type:
- Article
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1032397
- By:
- Publication type:
- Article
Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1033871
- By:
- Publication type:
- Article
SIRPα Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid Malignancies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.904718
- By:
- Publication type:
- Article
Mitigating infection risks: The promise and challenge of bispecific antibodies in haematological malignancies.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 764, doi. 10.1111/bjh.19668
- By:
- Publication type:
- Article
Development and validation of a patient‐reported outcome measure to assess symptom burden after chimeric antigen receptor T‐cell therapy.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 4, p. 738, doi. 10.1111/bjh.18677
- By:
- Publication type:
- Article
Positron emission tomography derived metrics in relapsed or refractory large B‐cell lymphoma with residual disease before autologous stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 35, doi. 10.1111/bjh.18441
- By:
- Publication type:
- Article
Evidence of robust memory T‐cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2).
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 692, doi. 10.1111/bjh.17402
- By:
- Publication type:
- Article
Chimeric antigen receptor (CAR) natural killer (NK)‐cell therapy: leveraging the power of innate immunity.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 216, doi. 10.1111/bjh.17186
- By:
- Publication type:
- Article
Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the absence of GVHD prophylaxis.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 5, p. 754, doi. 10.1111/bjh.15970
- By:
- Publication type:
- Article
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 4, p. 567, doi. 10.1111/bjh.14596
- By:
- Publication type:
- Article
Immunotherapy for infectious diseases in haematological immunocompromise.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 348, doi. 10.1111/bjh.14595
- By:
- Publication type:
- Article
Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/ MDS.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 3, p. 427, doi. 10.1111/bjh.14244
- By:
- Publication type:
- Article
Excellent outcome after repeated changes of tyrosine kinase inhibitor therapy for chronic myeloid leukaemia in complete cytogenetic response due to minor side effects.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 4, p. 608, doi. 10.1111/bjh.12648
- By:
- Publication type:
- Article
The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04117-3
- By:
- Publication type:
- Article
Results of a phase I trial with Haploidentical mbIL‐21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 890, doi. 10.1002/ajh.27281
- By:
- Publication type:
- Article
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 562, doi. 10.1002/ajh.27233
- By:
- Publication type:
- Article
Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. 38, doi. 10.1002/ajh.27126
- By:
- Publication type:
- Article
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. 712, doi. 10.1002/ajh.26870
- By:
- Publication type:
- Article
Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02444
- By:
- Publication type:
- Article
Human NK Cells Develop an Exhaustion Phenotype During Polar Degranulation at the Aspergillus fumigatus Hyphal Synapse.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02344
- By:
- Publication type:
- Article
Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00283
- By:
- Publication type:
- Article
Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2017.01937
- By:
- Publication type:
- Article
Characterizing cancer metabolism from bulk and single-cell RNA-seq data using METAFlux.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40457-w
- By:
- Publication type:
- Article
Bi-order multimodal integration of single-cell data.
- Published in:
- Genome Biology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13059-022-02679-x
- By:
- Publication type:
- Article
Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0139851
- By:
- Publication type:
- Article
Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1125, doi. 10.1007/s00262-011-1187-z
- By:
- Publication type:
- Article
Concise Review: Umbilical Cord Blood Transplantation: Past, Present, and Future.
- Published in:
- Stem Cells Translational Medicine, 2014, v. 3, n. 12, p. 1435, doi. 10.5966/sctm.2014-0151
- By:
- Publication type:
- Article
Editorial: Cellular Therapies in Cancer.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Chimeric antigen receptor T‐cell therapy toxicities.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 6, p. 2414, doi. 10.1111/bcp.14403
- By:
- Publication type:
- Article
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment.
- Published in:
- Life Science Alliance, 2022, v. 5, n. 12, p. 1, doi. 10.26508/lsa.202201590
- By:
- Publication type:
- Article
Next‐generation chimeric antigen receptors for T‐ and natural killer‐cell therapies against cancer.
- Published in:
- Immunological Reviews, 2023, v. 320, n. 1, p. 217, doi. 10.1111/imr.13255
- By:
- Publication type:
- Article
Vaccination Strategies in Lymphomas and Leukaemias: Recent Progress.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
New and emerging therapies for acute and chronic graft versus host disease.
- Published in:
- Therapeutic Advances in Hematology, 2018, v. 9, n. 1, p. 21, doi. 10.1177/2040620717741860
- By:
- Publication type:
- Article
Lenalidomide-induced graft-vs.-Leukemia effect in a patient with chronic lymphocytic leukemia who relapsed after allogeneic stem cell transplant.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The Development of a Myeloablative, Reduced-Toxicity, Conditioning Regimen for Cord Blood Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2014, v. 14, n. 1, p. e1, doi. 10.1016/j.clml.2013.08.006
- By:
- Publication type:
- Article
Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.
- Published in:
- European Journal of Haematology, 2005, v. 75, n. 5, p. 376, doi. 10.1111/j.1600-0609.2005.00531.x
- By:
- Publication type:
- Article
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022).
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04117-3
- By:
- Publication type:
- Article
High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.675679
- By:
- Publication type:
- Article
CT-046: Post-Transplant Cyclophosphamide in HLA-Matched and Haploidentical Transplant Recipients Receiving a Myeloablative Fractionated Busulfan Conditioning Regimen: Results of a Phase II Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S446, doi. 10.1016/S2152-2650(21)01992-3
- By:
- Publication type:
- Article
Poster: CT-046: Post-Transplant Cyclophosphamide in HLA-Matched and Haploidentical Transplant Recipients Receiving a Myeloablative Fractionated Busulfan Conditioning Regimen: Results of a Phase II Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S258, doi. 10.1016/S2152-2650(21)01627-X
- By:
- Publication type:
- Article
Cytotoxic Lymphocytes for Viral Infection.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S192, doi. 10.1016/S2152-2650(21)01263-5
- By:
- Publication type:
- Article
The Future of Cellular Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S102, doi. 10.1016/j.clml.2019.07.436
- By:
- Publication type:
- Article
A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Engineering the next generation of CAR-NK immunotherapies.
- Published in:
- International Journal of Hematology, 2021, v. 114, n. 5, p. 554, doi. 10.1007/s12185-021-03209-4
- By:
- Publication type:
- Article
NK cell therapy for hematologic malignancies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
CAR‐NK cells: the next wave of cellular therapy for cancer.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 4, p. 1, doi. 10.1002/cti2.1274
- By:
- Publication type:
- Article
The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Autologous haematopoietic stem cell transplantation in multiple myeloma patients from ethnic minority groups in an equal access healthcare system.
- Published in:
- British Journal of Haematology, 2012, v. 157, n. 1, p. 125, doi. 10.1111/j.1365-2141.2011.08906.x
- By:
- Publication type:
- Article
Does a rise in the BCR-ABL1 transcript level identify chronic phase CML patients responding to imatinib who have a high risk of cytogenetic relapse?
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 3, p. 373, doi. 10.1111/j.1365-2141.2009.07646.x
- By:
- Publication type:
- Article